(2) Mechanistically, HIF-1α activation by ROX treatment resulted in intracellular iron deficiency in brain via downregulation of hepcidin expression, which lead to the enhanced iron exporter via FPN1. The gene discussed is SLC40A1; the disease is nutritional disorder.